Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
1066052
Title:
CELLULES DE SOUCHE MESENCHYMATEUSE SERVANT A LA PREVENTION ET AU TRAITEMENT DES REPONSES IMMUNITAIRES LORS DE LA TRANSPLANTATION
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
999138761
WO application number:
US1999005548
Type:
European patent granted for BE
Status:
Expired
Publication number:
1066052
WO publication number:
WO 1999/047163
1rst applicant's nationality:
Translation language:
French
EPO publication language:
English
SPC number:
Dates
Filing date:
12/03/1999
Grant date:
01/02/2006
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
02/05/2006
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
01/02/2006
EP B1 publication date:
01/02/2006
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
12/03/2019
Applicant
1
Name:
Mesoblast International Sàrl
Legal Form:
From:
02/08/2018
Address:
Route de Pré-Bois 20, 1217 Meyrin, Switzerland (CH)
To:
2
Name:
Osiris Therapeutics, Inc.
Legal Form:
From:
02/08/2018
Address:
7015 Albert Einstein Avenue, Columbia, Maryland 21046, United States (US)